1 Medical Oncology, MNJ Institute of Oncology and Regional Cancer Center , Hyderabad, India .
2 Faculty of Medicine, Lund University , Lund, Sweden .
J Palliat Med. 2018 Aug;21(8):1100-1106. doi: 10.1089/jpm.2017.0695. Epub 2018 May 16.
To study to what extent tumor-specific treatment (chemo- or radiotherapy) was given during the last 30 days in life and to examine how many of the patients were referred to a specialized palliative care unit (PCU), at a low-resource governmental hospital in India.
Medical records of adult cancer patients deceased between April 1 and May 31 in 2016, and pediatric cancer patients deceased between April 1 and September 30 in 2016 were collected. Data regarding gender, age at admission, cancer diagnosis, tumor-specific treatment received, referral to the PCU, and date of death, were sampled.
A total of 96 patients (52 adults and 44 pediatric patients) were included in the study. In the last 30 days of life, tumor-specific treatment was given to 39 adult patients and 38 pediatric patients. During the last week in life, 26 adult and 25 pediatric patients, respectively, received tumor-specific treatment. Twenty-six adult and 25 pediatric patients, respectively, were referred to the PCU. End-of-life (EoL) tumor therapy was given to a lesser extent among referred patients.
Eighty percent of the patients were given tumor-specific treatment near EoL. Half of the patients had been referred for specialized palliative care (SPC).
研究在生命的最后 30 天内给予肿瘤特异性治疗（化疗或放疗）的程度，并检查有多少患者被转介到印度一家资源有限的政府医院的专门姑息治疗病房（PCU）。
收集了 2016 年 4 月 1 日至 5 月 31 日期间死亡的成年癌症患者和 2016 年 4 月 1 日至 9 月 30 日期间死亡的儿科癌症患者的病历。采样了有关性别、入院时年龄、癌症诊断、接受的肿瘤特异性治疗、转介至 PCU 以及死亡日期的数据。
共有 96 名患者（52 名成年患者和 44 名儿科患者）纳入研究。在生命的最后 30 天内，39 名成年患者和 38 名儿科患者接受了肿瘤特异性治疗。在生命的最后一周内，分别有 26 名成年患者和 25 名儿科患者接受了肿瘤特异性治疗。分别有 26 名成年患者和 25 名儿科患者被转介到 PCU。在接受转介的患者中，临终期肿瘤治疗的比例较低。
80%的患者在临终期接受了肿瘤特异性治疗。有一半的患者已经接受了专门的姑息治疗（SPC）。
